Investigational Drug Information for nirmatrelvir
✉ Email this page to a colleague
What is the drug development status for nirmatrelvir?
nirmatrelvir is an investigational drug.
There have been 22 clinical trials for nirmatrelvir.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 21st 2023.
The most common disease conditions in clinical trials are COVID-19, Coronavirus Infections, and Tachycardia. The leading clinical trial sponsors are Pfizer, Sponsor GmbH, and Karolinska University Hospital.
There is one US patent protecting this investigational drug and forty-four international patents.
Summary for nirmatrelvir
US Patents | 1 |
International Patents | 44 |
US Patent Applications | 4 |
WIPO Patent Applications | 3 |
Japanese Patent Applications | 0 |
Clinical Trial Progress | Phase 3 (2023-01-21) |
Vendors | 23 |
Recent Clinical Trials for nirmatrelvir
Title | Sponsor | Phase |
---|---|---|
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin | Pfizer | Phase 1 |
Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities | National Taiwan University Hospital | Phase 2/Phase 3 |
imPROving Quality of LIFe In the Long COVID Patient | Karolinska University Hospital | Phase 2 |
Clinical Trial Summary for nirmatrelvir
Top disease conditions for nirmatrelvir
Top clinical trial sponsors for nirmatrelvir
US Patents for nirmatrelvir
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
nirmatrelvir | ⤷ Try a Trial | ⤷ Try a Trial | ||
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for nirmatrelvir
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
nirmatrelvir | Argentina | AR123111 | 2040-09-03 | ⤷ Try a Trial |
nirmatrelvir | Australia | AU2021266232 | 2040-09-03 | ⤷ Try a Trial |
nirmatrelvir | Australia | AU2022202158 | 2040-09-03 | ⤷ Try a Trial |
nirmatrelvir | Australia | AU2022221493 | 2040-09-03 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |